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Almost all health care interventions have the potential to be associated with risk to patient 
safety. Different terminologies are used to define treatment induced risk to patient safety and  
a common definition is the term adverse effect. Beyond the concept of adverse effect and 
specific to homeopathy is the concept of homeopathic aggravation. Homeopathic aggravation 
describes a transient worsening of the patients’ symptoms, which is not understood as an 
adverse effect. In order to ensure patient safety within a homeopathic treatment setting, it is 
important to identify adverse effects, as well as homeopathic aggravations, even though it 
may be challenging to distinguish between these two concepts. To date there is an obvious 
lack of systematic information on how adverse effects and homeopathic aggravations are 
reported in studies. This systematic review and meta-analysis focuses on observational 
studies, as a substantial amount of the research base for homeopathy are observational.  
Method 
Eight electronic databases, central webpages and journals were searched for eligible studies. 
The searches were limited from the year 1995 to January 2020. The filters used were 
observational studies, human, English and German language. Adverse effects and 
homeopathic aggravations were identified and graded according to The Common 
Terminology Criteria for Adverse Effects (CTCAE). Meta-analysis was performed separately 
for adverse effects and homeopathic aggravations. 
Results 
A total of 1,169 studies were identified, 41 were included in this review. Eighteen studies 
were included in a meta-analysis that made an overall comparison between homeopathy and 
control (conventional medicine and herbs). Eighty-seven per cent (n=35) of the studies 
reported adverse effects. They were graded as CTCAE 1, 2 or 3 and equally distributed 
between the intervention and control groups. Homeopathic aggravations were reported in 
22,5% (n=9) of the studies and graded as CTCAE 1 or 2. 
The frequency of adverse effects for control versus homeopathy was statistically significant 
(P < 0.0001). Analysis of sub-groups indicated that, compared to homeopathy, the number of 
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adverse effects was significantly higher for conventional medicine (P=0.0001), as well as 
other complementary therapies (P=0.05).  
Conclusion 
Adverse effects of homeopathic remedies are consistently reported in observational studies, 
while homeopathic aggravations are less documented. This meta-analysis revealed that the 
proportion of patients experiencing adverse effects was significantly higher when receiving 
conventional medicine and herbs, compared to patients receiving homeopathy. Nonetheless, 
the development and implementation of a standardized reporting system of adverse effects in 
homeopathic studies is warranted in order to facilitate future risk assessments.  
Keywords: Adverse effects; adverse events; homeopathic aggravation; patient safety; risk 
assessment; systematic review; meta-analysis; observational studies. 
Background 
Almost all health care interventions are associated with potential risk and are as such 
associated with adverse effects of different typology (1). However, data on adverse effects are 
often sparse and not well reported, even though the absence of information does not mean that 
the intervention is safe (2). Only systematic reporting of the occurrence of adverse effects 
related to a treatment provides patients as well as health care providers with the data to 
evaluate the advantages and disadvantages of a  treatment (2, 3). Information about treatment 
effectiveness and associated risks are essential in order to estimate the cost-benefit relation of 
an intervention. However, systematic reviews with the primary objective to assess harms and 
risks count for less than 10% of all systematic reviews published annually (2).  
Homeopathic medicine was established and developed in Germany by Samuel Hahnemann in 
the late 18th century. As the mechanisms of action of homeopathic remedies are still unclear, 
this form of treatment is controversial. Possible risks associated with homeopathy have been 
poorly investigated, often due to the assumption that homeopathy and many complementary 
modalities are considered to be without effect or “natural”, and therefore associated with low 
risk. Adverse effects of homeopathic remedies have been investigated by Dantas and Rampes 
(4). They found that 9% of the patients using homeopathic remedies reported adverse effects, 
in contrast to 6% in the placebo groups. The adverse effects were minor, transient and 
comparable. In 2016, Stub et al. concluded in a systematic review and meta-analysis that 
adverse effects as well as homeopathic aggravations are frequently, and systematically 
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reported in clinical trials on homeopathy. The meta-analysis revealed that the proportion of 
patients experiencing adverse effects was similar for patients randomized to homeopathic 
treatment compared to patients randomized to placebo and conventional medicine (5).  
Concept and terminology 
Operationally and methodologically, risk is defined as a compound measurement of the 
probability of an event and the magnitude of the potential negative outcome of that event (6).  
Many terms are used to describe harms associated with health care interventions. According 
to the Cochrane handbook for systematic reviews of an intervention (1), the term  adverse effect 
is understood as an adverse event for which the causal relation between the intervention and 
the event is at least a reasonable possibility. Adverse event is defined as an unfavorable 
outcome that occurs during or after the use of drugs or other interventions but is not 
necessarily caused by it. According to Edward and Aronson (7), the term adverse effect in the 
above described understanding must be distinguished from the term adverse event. They 
understand adverse event as an adverse outcome that occurs while a patient is taking a drug, 
thus, there is a strong temporal association to the drug, but the harmful event must not 
necessarily be associated with it. The term adverse effect encompass all unwanted effects, 
without making assumptions about their mechanisms. This definition term includes in fact 
more sources of risk than those directly related to the drugs and thus covers a broader 
spectrum of potential risks.  
The homeopathic intervention is a complex treatment situation that consists of in-depth 
consultations often reaching beyond the bodily complaints and involving psychological 
problems. Thus while assessing homeopathic interventional trial with the aim to include as 
many sources of risk as possible, a broad definition of risk is desirable. Therefore, we agreed 
on the term and definition of “adverse effect” according to (1) for the risk analysis of such a 
complex treatment situation  as homeopathy. This term and understanding of harm was 
utilized for the purpose of this review, being aware of, that this represents more a pragmatic 
definition and that other approaches maybe likewise possible and justified (7).  
For the purpose of this review, Homeopathic aggravation, is defined as “a temporary 
worsening of existing symptoms following the administration of a correctly chosen 
homeopathic remedy” (8-10). In homeopathic theory, such a reaction is seen as a favourable 
response to treatment and is expected to be followed by improvement. Thus, the concept of 
homeopathic aggravation imposes a particular risk for patients within a homeopathic 
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treatment setting as it allows the patients’ health status to decline prior to a possible 
improvement. In a systematic review of homeopathic aggravations, Grabia and Ernst (11) 
found that eight out of 25 trials reported homeopathic aggravations and six reported adverse 
effects. The authors claimed that, for safety reasons, both concepts should be reported in 
trials. In clinical practice, an unneglectable risk in homeopaths may be the misinterpretation 
of symptom worsening as a homeopathic aggravation. If treatment is then continued, instead 
of referring patients with severe/deteriorating symptoms to conventional care, this risk may be 
substantial (12). Thus, if the total risk related to homeopathic treatment is to be assessed, both 
concepts, the likelihood of homeopathic aggravations as well as the likelihood of adverse 
effects need to be assessed.  
Therapeutic effect studies are commonly randomized controlled trials (RCT’s ) and we have 
previously conducted and published a systematic review and meta-analysis on risk of 
homeopathy in  RCT’s (5) . Adverse effects, however, may also be effectively investigated in 
non-randomized studies (13). In addition, rare adverse effects or long-term adverse effects are 
rather unlikely to be observed in RCT’s due to the strictly controlled study conditions. 
Therefore, with regard to estimating the frequency of adverse effects, a thorough investigation 
requires also the inclusion of observational studies (1). Vandenbroucke (14) proposed that 
observational studies of adverse effects offer some of the best opportunities for unbiased 
research, and that observational research is methodologically superior if the focus is placed on 
the detection of unexpected adverse effects. Papanikolaou (15) compared the risks of 13 major 
harms due to medical interventions using data from both RCT’s and observational studies. 
The results suggested that if a non-randomized study finds harm, chances are that a 
randomized study would find even greater harm in terms of the magnitude of absolute risk. 
The authors concluded, that non-randomized studies were more precise in detecting estimates 
of risk compared to RCT’s.  
Aims  
Thus, in order to investigate how often adverse effects and homeopathic aggravations are 
reported in observational studies on homeopathy, we conducted a systematic review and 
meta-analysis. Nonetheless, it is important to bear in mind, that the information available on 
adverse effects and homeopathic aggravations  is based exclusively on the information 
provided by the authors of the included studies and may thus be subject to reporting bias.. 
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The aims of this review were to i) systematically investigate how homeopathic aggravations 
and adverse effects are reported in observational studies. ii) Classify adverse effects and 
homeopathic aggravations according to their severity using  the Common Terminology 
Criteria for Adverse Effects (CTCAE) (16). iii) Perform a meta-analysis to evaluate the risk 
for patients using homeopathy (consultation/and/or homeopathic remedies) compared to 
controls (conventional medicines/other complementary therapies). 
Methods 
Searches 
The focused question was: 
Is homeopathy associated with adverse effects and/or homeopathic aggravations? 
The PICOS format was used when searching for relevant articles, which included the 
following four parts: 
Population: Patients using homeopathy, physicians and homeopaths who reported adverse     
effects and homeopathic aggravations in the included studies 
Intervention: Homeopathy, including everything a homeopath does in the consultation, such 
as a diagnostic in-depth interview, individual prescription of homeopathic 
remedies and life-style advice, as well as the use of complex homeopathic 
remedies 
Comparison: Conventional medicines, usual care, waiting lists, other complementary and 
alternative (CAM) treatments (including herbs) 
Outcome: Adverse effects, adverse events, adverse drug reactions, tolerability, side 
effects (or other safety terminology) and homeopathic aggravations 
Study-type: Observational studies (including prospective and retrospective studies), cohort 





Eight electronic databases, central webpages and journals were searched for eligible studies: 
AMED, Cinahl, Cochrane Central Register for Crolled Trial (Central) in the Cochrane library, 
Embase, PsycINFO, PubMed, CAM Quest, CAMbase, Thieme eJournals and Karger. A 
manual search was performed in the grey literature such as conference proceedings, 
unpublished studies, and study protocols. References of all included studies were hand 
searched for additional eligible studies according to the search methodology of the Cochrane 
Information Retrieval Methods Group {Lefebvre C, 2012 #2563}.   
Search Methods: Various combinations of controlled vocabulary/thesaurus terms and text 
words, adjusted for each database, were used. The following controlled terms were used: 
Homeopathy/Materia Medica/Risk factors /Safety /Observational study/Cohort studies/Case-
control studies. These text words were used: homeopathy/homeopathic/adverse effect/adverse 
event/side effects/harm/safety/homeopathic aggravation/outcome/effects. The filters were 
human, English, German and Scandinavian languages. The searches were limited to the time 
period from January 1995 to January 2020. Two authors, TS and GO developed the search 
strategy and performed the searches. TS read the articles, and extracted the data together with 
AEK. (The search strategies from PubMed and Central (Cochrane) are attached as 
supplemental material).  
The inclusion comprised observational studies (cohort studies, non-randomized controlled 
studies, case-control and clinical studies) that reported adverse effects and/or homeopathic 
aggravations (or other safety terminology) of the intervention. Any human condition and 
homeopathic modality were considered. The excluded studies had no documentation of 
homeopathic aggravations or adverse effects. Moreover, all homeopathic proving trials, and 
homeopathic pathogenic trials were excluded. Adverse effects and homeopathic aggravations 
were recorded as reported and stated in the included studies. 
Methodological assessment of the studies 
Data from observational studies were validated and extracted according to ten technical 
items(18): Indication, sample size, baseline comparability, inclusion/exclusion criteria, 
intervention, dropout, objective, duration of treatment, main results and funding (table 1). 
Checklists used to critically appraise observational studies tend to concentrate on issues of 
external and internal validity, including items like comparability of subjects, details of 
intervention and outcome measures, statistical analysis, and funding (19, 20). Thus, these 
recommended items are in line with those applied in this systematic review. For 
methodological assessment of included studies, articles were exported to the System for the 
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Unified Management, Assessment and Review of Information (SUMARI software program, 
Joanna Briggs Institute) (21) for critical appraisal of study quality. Two reviewers (TS, MJ) 
independently rated the methodological quality of included articles using the critical appraisal 
checklists in SUMARI. Discrepancies between the reviewer’s quality assessments were 
discussed with a third reviewer (AEK) and resolved. For the purpose of this systematic 
review, articles with ≥ 75% positive (yes) score on the critical appraisal items were classified 
to be of high quality, from 50-74% of medium quality, and < 50% of low quality. 
Total number and grading of adverse effects and homeopathic aggravations 
Studies were extracted for data on adverse effects and homeopathic aggravations according to 
six criteria: Sample size, total number of adverse effects, number of participants experienced 
adverse effects, total number of homeopathic aggravations, number of participants 
experienced homeopathic aggravations, and grading of symptoms according to The CTCAE 
(22). When summarizing the data, the total number of adverse effects and homeopathic 
aggravations was rated, regardless of the number of participants who experienced them. 
Adverse effects and homeopathic aggravations were recorded as reported in the included 
studies. This means that one study participant could experience and report several adverse 
effects.  
Grading of symptoms 
We choose to apply an established grading system for adverse effects used in conventional 
medicine. This was done to make the results comparable to studies from conventional care. In 
addition and with the aim to make homeopathic aggravations more comparable to the concept 
of adverse effects, the CTCAE grading system was also applied to homeopathic aggravations. 
As mentioned above, adverse effects and homeopathic aggravations were recorded as reported 
and stated in the included studies. This means that The CTCAE grading is entirely dependent 
on the information provided in the included studies. The symptoms were classified and graded 
by the first and second author.  
Meta-analysis on adverse effects 
For the calculation of the meta-analysis, the study populations were divided into patients who 
experienced adverse effects vs. patients who did not experience adverse effects in both the 
homeopathy and control groups. Moreover, studies that recorded the numbers of adverse 
effects without stating the respective number of patients affected by the adverse effects were 
excluded. If the studies were homogenous regarding the study design, participants, 
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interventions, control, and outcome measures, they were combined in a meta-analysis. 
Heterogeneity was defined significant if P < 0.10 (1).  
Based on the total number of participants in the treatment or control group, odds ratios and 
confidence intervals of 95% were calculated from the number of patients who experienced 
adverse effects in each group. In 11 studies with no adverse effects in one or both groups, a 
continuity correction of 0.5 was added to achieve a valid approximation of an odds ratio 
according to the current recommendations on analysing adverse effect data (23). To perform a 
meta-analysis, data were entered directly from the data sheets into Review Manager 5 
computer program (24). 
Results  
Outcome of the literature searches 
A total of 1,169 hits were identified. Five hits were identified in Amed; 63 in Cinahl; 196 in 
Embase; 40 in PsycInfo; 108 in Pubmed and 749 in Cochrane Central Register for Crolled 
Trial. A total of six studies were identified in German databases and finally, two hits were 
identified after searches in reference lists. These hits were examined on the basis of titles and 
abstracts. A total of 151 were excluded from further examination because they were 
duplicates and a total of 1018 studies were included. Of these, 969 were excluded for the 
following reasons: 521 were irrelevant (according to the criteria). Furthermore, the exclusion 
comprised 265 CAM therapies other than homeopathy, 44 homeopathic proving trials, and 60 
were studies in other languages than English, German or Scandinavian languages. A total of 
86 studies were excluded for not having reported adverse effects and/or homeopathic 
aggravations, and one study (25) was excluded due to insufficient data. Six studies (26-31) were 
included after searching German databases. A total of 41 observational studies (26-66) 
comprising 17,312 subjects were included in this review (figure 1). 
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Figure 1: Flow chart of the selection process of observational studies.*Irrelevant studies: 
Systematic reviews, guidelines, research reviews, cost-benefit evaluations, case-reports, letters, comments, 
debates, self-management, and other abstracts. 
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Methodological quality  
A total of 40 observational studies were included in the methodological assessment. Results 
from this evaluation demonstrated that five observational studies did not report baseline 
comparability (34, 40, 52, 61, 65), nine did not report exclusion criteria (30, 40, 47, 50-52, 54, 58, 62), and 
funding was not reported in 17 studies (26, 28-31, 33, 34, 40-42, 45, 47, 54, 55, 60, 61, 66). In table 1 the 
sample size refers to the total number of participants in the study. In the treatment and control 
groups, n refers to the number of participants who received the intervention. Dropout refers to 
the number of participants who left the study in the treatment and control group, respectively. 
Therefore, the number of participants who completed the study can be calculated as follows, 
e.g.: Birnesser 2004: Started with a total sample size of (n=184), (n=86) in the treatment 
group and (n=77) in the control group received intervention. The number of participants who 
left the study was (n=6) in the treatment group and (n=15) in the control group (table 1).  
Table 1: Methodological assessment of the observational studies. 
Based on the SUMMARI software program from Joanna Briggs Institute, the methodological 
quality of the included studies was rated as high too medium for 75% of the studies and 24.6 
% of the studies was assessed as low quality. The assessment table for each included study is 
attached as a supplementary file.    
Adverse effects  
A total of 36 (90%) studies reported 2,498 adverse effects in 17,312 participants, 2,155 in the 
treatment groups and 343 in the control groups. Four studies reported only homeopathic 
aggravations. The patients and/or practitioners/physicians reported them. A total of (n=824) 
harmful events were graded according to The CTCAE grading system. In the homeopathy 
group: 55% were graded as CTCAE 1 (minor), 42% as grade 2 (moderate), and 3% as grade 3 
(severe). In the control groups 57% were graded as CTCAE 1 (minor), 39% as CTCAE 2 
(moderate), and 4% as CTCAE 3 (severe). No-events were graded as CTCAE 4 and 5.  
Adverse effects were measured on a three or four point tolerability scale (very good, good, 
moderate and low) in 13 studies (27-30, 32, 33, 38, 42-44, 60, 64, 66). Seven studies (29, 34, 38, 41, 43, 44, 
49) measured adverse effects as mild, moderate, and severe. Four studies (26, 42, 57, 60) reported 
harmful events descriptively. Two studies (54, 62) applied the term side effects, two studies 
used adverse reactions (35, 43), one study used the term adverse drug reaction (ADR) (56), and 
one study measured patient satisfaction on a rating scale (39). Twelve studies reported that the 
treatment was “very well tolerated” in both the conventional and homeopathic groups (28, 30, 
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32, 33, 38, 41-44, 60, 64, 66). The majority of the adverse effects was categorized as gastro-intestinal 
disorders, headache/dizziness, dermatitis or skin rashes, upper respiratory tract infections and 
allergic reactions.  
Homeopathic aggravations  
A total of nine studies (22,5%) (34, 40, 45-48, 56, 63, 65) reported 97 homeopathic aggravations in 
the treatment groups. Of these, four reported only homeopathic aggravations, and five 
reported both homeopathic aggravation and adverse effects. A total of (n=83) was graded 
according to The CTCAE grading system. Of these 47% (n=39) were graded as CTCAE 1 
(minor) and 53% (n=44) as 2 (moderate). No events were graded as CTCAE 3, 4 and 5. 
Homeopathic aggravations were descriptively reported in seven studies (42, 46-48, 60, 64, 65). The 
physicians classified homeopathic aggravations in six of the studies (49-53, 58). The 
aggravations were mostly characterized as exacerbation of eczema, psoriasis, atopic 
dermatitis, varicose eczema, asthma, headache, fever, sickness, allergy, pain, hot flushes, ear 
infections, aggravation of bulimia, urticarial, and lichen simplex.  
The control interventions 
The control intervention was conventional medicine in sixteen studies (38, 41-43, 49, 59, 
62);(32);(35); (36);(60);(27, 33, 39, 44, 57) and complementary therapy (herbs) in two studies (64, 66).  
Key data are summarized in table 2 (table 2). 
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Table 2: Classification of the total number of adverse effects and homeopathic aggravations 
in the observational studies  
Remedies associated with adverse effects and homeopathic aggravations 
Both complex and single remedies were associated with adverse effects or homeopathic 
aggravations. The potencies used in these remedies were both low (potencies below C30) and 
high (potencies from C200 to C10000). Six observational studies (49-53, 58) found that 95 single 
remedies were associated with homeopathic aggravations. The time-aspect (time from when 
the remedy was administered to when the reaction occurred) was generally poorly reported in 
the included studies. Therefore, we could not evaluate whether these aggravations should be 
classified as adverse effects. 
Meta-analysis on adverse effects 
Eighteen observational studies (n=18) with 9,310 participants were included in the statistical 
analysis. Studies included in the meta-analysis consisted of two groups [intervention 
(homeopathy) versus control (conventional medicine and herbs)]. The conventional therapies 
consisted of drugs such as NSAIDs, antibiotics, corticosteroids, nasal preparations, ACT 
inhibitors, and analgesics. For a complete description, see table 1. 
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Homeopathy versus overall control 
An overall comparison was made between homeopathy and control. 18 studies (n=18) with 
9,310 participants were included in this analysis. A statistical significant difference was found 
between homeopathy and control with OR 0.87, 95% CI 0.81 to 0.93, I2 = 39%, (P = < 
0.0001). There were less adverse effects in the homeopathy groups. 
Different subgroup meta-analyses according to the categories of controls were performed and 
is presented below. 
Homeopathy versus conventional medication 
A comparison was made between homeopathy and conventional medicine. Sixteen studies 
(8,164 participants) made this comparison. A statistical significant difference was found 
between homeopathy and conventional medicine with OR 0.83, 95% CI 0.76 to 0.92, I2 = 
43%, (P = 0.0004). There were more adverse effects in the conventional medicine groups. 
Homeopathy versus Valerian (a complementary therapy) 
A comparison was made between homeopathy and other complementary therapies (Valerian). 
Two studies (1,146 participants) made this comparison. No statistical difference was found 
between homeopathy and complementary therapies with OR 0.91, 95% CI 0.83 to 1.00, I2 = 0, 
(P = 0.05). There were more adverse effects in the Valerian groups (figure 2). 
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Figure 2: Forest plot for the observational studies, including sub-group analysis according to 
the category of controls  
We excluded 22 observational studies from the meta-analysis because of the following 
reasons: 
1)  No comparison group (n=18) (26, 28-31, 34, 37, 47, 48, 50-56, 58, 61, 63)  
2)  Reported data only on homeopathic aggravations (n=4) (40, 45, 46, 65) 
 
Discussion 
This systematic review and meta-analysis demonstrated that the proportion of patients 
experiencing adverse effects was significantly higher when receiving conventional medicine 
or other complementary therapies (Valerian), compared to patients receiving homeopathy. 
The severity of harmful events was mostly minor and moderate according to the CTCAE 
system and they were equally distributed between the homeopathy and control groups. 
Homeopathic aggravations were likewise reported in the homeopathy groups and they were 
also classified as minor to moderate events according to the CTCAE grading system. 
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Bias consideration 
We decided to perform a meta-analysis with a simple random effect model (67). This model is 
recommended in meta-analyses of rare binary adverse effects data (23). According to Friedrich 
et al. (68) we decided to include studies with zero-cell counts because the exclusion of such 
studies enhances the "risk of inflating the magnitude of the pooled treatment effect". By using 
a continuity correction of 0.5 for studies with zero-cell counts, odds ratio can still be 
estimated and summed up with standard meta-analysis methods. The inclusion of zero event 
studies is particularly important in cases of adverse effects as applying the standard continuity 
correction leads to a conservative, but error free approximation of the risk of adverse effects 
(67). Moreover, the sample size of these studies contributes to the total effect size and makes 
this more valid. 
To address the question about reporting bias, we performed a funnel plot (attached as 
supplementary material). The plot was made with sample size and odds ratio data from this 
review. The graph resembled a symmetrical inverted funnel, meaning no publication bias was 
present in the studies included in this review (1). 
It is generally difficult to receive funding for research on homeopathy. Thus, funding from the 
homeopathic industry is often the only possibility. It has been suggested that studies funded 
by the pharmacological industry are associated with outcomes that are favorable to the funder. 
In a systematic review, Lexichin et al. (69) identified 30 studies published between 1966 and 
2002 that examined whether funding of drug studies by pharmacological companies were 
associated with outcomes that are favorable to the sponsor. They found that studies sponsored 
by pharmacological companies were more likely to have outcomes favoring the sponsor than 
studies with sponsors outside the pharmaceutical industry. In addition, such studies were less 
likely to be published. This result is in line with other reports (70, 71). In the present review, 
only 11 studies (26.8%) (27{Haidvogl M, 2007 #584, 32, 33, 38, 39, 41, 43, 44, 64, 72)} of the 41 studies were 
sponsored by the industry that produced the homeopathic remedies under investigation, and 
the main findings of these studies revealed that homeopathy was as effective as conventional 
medicine. This number of studies indicates that funding from the pharmaceutical industry was 
of some concern in this review. 
The CTCAE grading of adverse effects and homeopathic aggravations was solely based on 
the information provided in the articles included in this review. The grading must, therefore, 
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be interpreted with care. As such, the grading applied here should be understood as merely an 
approximation to a CTCAE grading. 
Efforts have been made to retrieve all observational studies of interest, but it is impossible to 
be entirely certain that all potentially eligible studies have been found. The additional 
searches in German databases, a country with a strong homeopathic research tradition, 
strengthen the possibility that the majority of the studies available were included in this 
review.  
Other studies 
A total of 97 cases of homeopathic aggravations in 17,312 participants (0.55%) were found in 
this review, which is contrary to a previous review by Grabia and Ernst (11) who reported a 
total of 103 cases of homeopathic aggravations in 3,437 participants (3%). Moreover, a 
survey performed among Norwegian homeopath patients found a prevalence of 17% for 
worsening of symptoms that were classified as homeopathic aggravations (73). In other studies, 
the prevalence of homeopathic aggravations fluctuated between 6 (74) and 8% (40). Due to lack 
of adequate reporting systems, the real number of homeopathic aggravations may be 
underestimated. These data suggest that the prevalence of homeopathic aggravations 
fluctuates between 0.5%-17%. 
Homeopathic aggravations were reported as intensification of the patients’ present symptoms 
and are regarded to be in line with homeopathic theory (9, 75, 76). Various skin complaints, such 
as atopic eczema, psoriasis, and dermatitis, deteriorated initially, a result that is in line with 
previous reports (12, 77, 78). 
The adverse effects found in this review, were graded as minor and moderate events. This 
result is in line with Dantas and Rampes (4) who concluded that adverse effects connected to 
homeopathy are found to be minor, transient events. Results from the present review found 
that patients receiving conventional medicine experienced more adverse effects than those 
who received homeopathy. This result is not surprising as conventional medicine can be 
expected to be pharmacologically active and may therefore be associated with more adverse 
effects. This is especially true for homeopathic remedies of high dilution which cannot have 
pharmacological effect and a direct toxicological risk from these remedies is therefore 
impossible. Homeopathic remedies of low dilutions, on the other hand, are connected with 
direct risk as they are pharmacologically active. Homeopathic remedies of both low and high 
dilutions were investigated in this review. 
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 In 2016, this research group published a systematic review on adverse effects of homeopathy 
of RCTs (5). By comparing these two reviews we found that adverse effects were reported to a 
higher degree in observational studies (87.5%) than in RCTs (68%). Homeopathic 
aggravations were reported in 22.5% of the observational studies and in 12% of the RCTs. 
These findings may support the assumption that RCTs, due to their highly controlled design, 
conditions may not necessarily reflect homeopathic every day practice and may thus 
underestimate adverse effects. Therefore, with regard to detecting adverse effects and thus 
patient safety, cohort studies may be more valid.  
Implication for practice 
This review indicates low safety concern for homeopathic treatment. This applies both to the 
homeopathic consultation as well as to the homeopathic remedy. However, due to some case 
reports of serious harm, it is important that homeopaths inform their patients to stay in contact 
if the worsening of symptoms lasts for more than three days (79).  
Implication for research 
While the methodological quality of the included studies was high, harmful events were 
reported using different terminologies. Hence, there is a need for a standardized systematic 
reporting of adverse effects in homeopathy in order to facilitate risk assessments. 
Conclusion 
This systematic review and meta-analysis suggests a lower risk for homeopathic treatment 
compared to conventional medicine. However, the development and implementation of a 
standardized reporting system of adverse effects in future homeopathic studies is warranted.  
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Table 1: Methodological assessment of observational studies
Study ID   Indication Intervention Dropout Objectives Duration of 
treatment 
Main results Funding
Sample size Baseline comparability Inclusion Exclusion Treatment vs Control (n) Treatment vs 
Control (n)  Days
Ammerschläger H, 2005 Upper respiratory 
tract infection
n= 502 patients; 
n=153 physicians
Patients in the treatment 
group were significantly 
younger
Patients with clinically 
proven rhinositis and 
sinusitis 
Patients with ongoing therapy with 
study medication or other 
rhinologica 
Homeopathic complex remedy 
Euphorbium comp. (n=413) 
versus Xylometazolin (n=326)
n=161 vs. n= 76 Evaluate the effects of homeopathic 
treatment for upper respiratory tract 
infections
28 Both groups showed clinically 
relevant reduction of disease 
specific symptoms. Euphorbium 
was found to be non inferior to 
Xylometazolin.
Biologische Heilmittel Heel 
GmbH
Birnesser H, 2004 Epicondylitis n=184 Small differences between 
groups
Diagnosed epicondylitis NR Traumeel S (n=86) vs NSAID 
(n=77)
n=6 vs n=15 Compare complex homeopathy  
with conventional medication
14 Traumeel was equivalent to NSAID, 
superior for rest pain and joint 
mobility
 A grant from Biologische 
Heilmittel Heel GmbH
Danesch U, 2008 Asthma Bronchiale n=41 patients; n=6 
CAM-oriented 
physicians
A single group which was 
descriptively reported in 
publication
Patients with clinically 
proven asthma bronchiale 
and asthma associated 
vegetative symptoms
Patients that took Asthmavoven 
within the last four weeks 
Adjuvant homeopathic 
treatment with Asthmavoven
NR Evaluate the effects of Asthmavoven 
on vegetative symptoms in patients 
with asthma bronciale
28 Significant improvements in 
asthma associated symtoms and 
reduction of conventional 
medication 
NR
Derasse M, 2005 Acute febrile 
infections
n=198 Greater frequency of rhinitis 
in homeopathy group
Children older than 11 
years
Patients without symptoms Viburcol (n=107) vs 
acetaminophen (n=91) 
NR Compare complex homeopathy with 
conventional medication
14 No significant differences between 
groups
A grant from Biologische 
Heilmittel Heel GmbH
Endrizzi C, 2005 Patients' experiences 
with homeopathic 
treatment
n=181 NR One follow-up visit at the 
Campo di Marte Hospital 
NR Irrelevant NR Assess the harm of classical 
homeopathic treatment
365 Adverse reactions were observed 
at a rate of 2.68% 
NR
Gründling C, 2012 Allergic disorders n=44 A single group which was 
descriptively reported in 
publication
Patients diagnosed with 
neurodermatitis, allergic 
rhinitis, allergic 
conjunctivitis and bronchial 
astma, minimum age of 9
NR Classical homeopathy in 
additional to conventional 
treatment (n=44)
n=8 To access the real-life efficacy of 
classical homeopathic treatment and 
the potential to reduce conventional 
medication dosage
112 All clinical symptoms were 
improved substansially.62% of the 
participants were able to 
discountine at least one 
medication
NR
Gruenwald U, 2008 Dust mite allergies n=103 patients were 
enrolled; n=8 CAM-
oriented physicians
A single group which was 
descriptively reported in 
publication
Patients with clinically 
proven dust mite allergy 
suffering from at least four 
symptoms
Patients with hypersensitivity against 
remedy ingredients, brain or liver 
diseases, alcohol abuse, epilepsy or 
pregnancy
Homeopathic treatment with 
Allergin D2 (Adhatova vasica)
NR Evaluate efficacy and safety of 
Adhatova vasica on patients with 
dust mite allergies
8 83% of the patients showed 
improvements in dust mite allergy 
symtoms. Safety was rated very 
good in more than 90% by patients 
and physicians 
NR
Haidvogl M, 2007 Acute ear and 
respiratory complaints
n=1,577 BMI, gender and  age 
differed significantly 
between groups
Older than one month, one 
main chief complaint (onset 
< 7 d before)
NR Individualized homeopathy 
(n=875) vs antibiotics, nasal 
preparations and analgesics 
(n=720)
n=345 vs n=109 Assess whether homeopathy was 
non inferior to conventional 
treatment
14 Significant differences between 
groups, in favour of homeopathy
The Holt organization, 
Karlsruhe, Germany
Hübner R, 2009 Nervousness/ 
restlessness
n=826 The Neurexan group tended 
to weigh less, fewer 
concomitant illnesses and 
had milder nervousness
Clinical symptoms of 
nervousness judged by the 
evaluating clinician
Using conventional or homeopathic 
medication for nervousness
Neurexan (n=571) vs Valerian 
(n=224)
n=20 vs n=11 Gather data on the effectiveness of 
complex homeopathy in a CAM 
setting
14 Significant improvement in the 
Neurexan group compared to the 
Valerian group
A grant from Heel GmbH
Itamura R, 2007 Chronic skin disease n=60 NR Diagnosed with skin disease 
by a dermatological 
specialist
NR Individualized homeopathy  in 
addition to conventional 
treatment (n=60)
NR Patient-reported and clinically 
observed effects of homeopathy
More than 90 Homeopathy may provide a good 
response in patients with chronic 
skin disease
NR
Keil T, 2008 Eczema in children n=118 Parents with higher 
education and use of CAM in 
homeopathy group
Previously not treated for 
eczema and itching by the 
study physician
NR Individualized homeopathy 
(n=54) vs Corticosteroids (n=64)
NR Assess whether homeopathy could 
improve eczema and QOL compared 
to conventional treatment
365 Eczema improved in both groups. 
No differences between groups. 
QOL improved more in the 
conventional group
The German sickness fund 
Innungskrankenkasse 
Hamburg 
Klopp R, 2009 Multimorbid elderly 
patients
n=20 patients Not reported in publication Multimorbid male patients 
aged between 75-84 years
Female patients, intake of antibiotics 
or cytostatics within the last 4 weeks, 
known immune deficits and related 
diseases (cancer, diabetes)
Treatment with Spenglersan 
Kolloid G (n=10) versus placebo 
(n=10)
NR Evaluate immunmodulating effects 
of Spenglersan Kolloid G
21 Significant effects with respect to 
immune modulating behaviour of 
white blood cells and 
improvements in local micro 
circulation 
NR
Marian F, 2006 Patients' satisfaction 
and adverse effects in 
primary care. Data 
from two cross-
sectional studies
n=3, 126 patients; 
n=170 GPs and 
medical homeopaths
Women and chronic patients 
answered more freguently 
than men and non-chronic 
patients
GPs' and homeopaths' who 
are members of the Swiss 
medical association for 
homeopaths 
NR Homeopathy: Approach and 
style not reported (n=1702) 
Conventional: Appropriate for 
the disease in question (n=1363)
n=61 Assess patients' satisfaction and 
adverse effects of homeopathic and 
conventional treatment
365 In primary care, patients' 
satisfaction with homeopathy was 
higher compared to conventional 
treatment 
The Swiss Federal Office of 
Public Health
Michalsen A, 2015 To generate data on 
safety and treatment 
effect of a complex 
homeopathic drug
n=1050 A single group which was 
descriptively reported in 
publication
Patients older than 1 year 
with no upper limitation of 
age with symptoms of an 
acute catarrhal 
disease/common cold/flu-
like infection and 
inflammation of the nose 
and throat
Allergy against any of the 
constituents of the study 
preparation,a diagnosis of 
tuberculosis, leucosis, collagenosis, 
multiple sclero-sis, HIV and 
autoimmune diseases. Children at an 
age below 1 year and pregnant or 
lactating 
Contramutan N Saft (a complex 
homeopathic preparation)
NR Assess safety and tresatment effect 
of  Contrmutan N Saft
8 60 adverse effects were reported 
in 46 patients by the physicians. 
Adverse drug reactions were 
reported in 14 patients. 
Homeopathic aggrevation was 
reported in one patient. All events 
were of mild to moderaste 
intensity
The study was sponsored by 
Cassella-med (Cologne, 
Germany),the holder of the 
marketing authorization of the 
study preparation.
Mojaver YN, 2007 Trigeminal neuralgia n=15 NR Physician confirmed 
trigeminal neuralgia
Patients who use immuno - 




n=0 Evaluate individualized homeopathy 
in treatment of trigeminus neuralgia
120 A statistical significant reduction in 
pain intensity and frequency were 
found
NR
               Participants                    Criteria
Study ID   Indication Intervention Dropout Objectives Duration of 
treatment 
Main results Funding
Sample size Baseline comparability Inclusion Exclusion Treatment vs Control (n) Treatment vs 
Control (n)  Days
               Participants                    Criteria
Müller-Krampe B, 2007 Gastrointestinal 
cramps in children
n=204 < 12years of 
age
The group was incompletely 
balanced for age,weigth and 
higth
Newly or recurrent 
diagnosed gastrointestinal 
or urethal cramps
<12years of age undergoing 
treatment for such cramps 
Spascupreel (n=99) vs Hyoscine 
butylbromide (n=105)
NR Compared two different treatment 
options
7 Both groups improved in 
symptoms. No statistical 
difference was found between the 
groups
NR
Nayak C, 2010 Acute rhinitis in 
children
n=784 A singel group which was 
descriptively reported in 
publication
 Children > 6 months old 
and < 15 years old with 
acute rhinitis < 7 days
NR Group of 13 individualized 
homeopathic remedies
n=146 Evaluate a group of individualized 
homeopathic remedies for acute 
rhinitis
7 Indicated the usefulness of 
homeopathy in the management 
of acute rhinitis 
The study received no funding
Nayak C, 2013  Diabetic neuropathy 
(DPN)
n=336  (247 were 
analyzed)
A single group which was 
descriptively reported in 
publication
Age over 30 years with 
diagnosed type 1 or type 2 
diabetes, average blood 
sugar level less than 8% ( 
HbA1c), sensory loss, 
diabetic distal symmetric 
polyneuropathy symptom 
score  ≥ 3, patient meets 
prescribing criteria for one 
of the 15 preselected 
homeopathic medicines
Diabetic mononeuropathy and 
amyotrophy,polyradiculopathy,auto
nomic neuropathy,abnormalities of 
gait,absent stretch reflexes, wrist and 
foot drop, charcot joints, paralysis of 
cranial nerves,loss of arch with 
multiple fractures of tarsal 
bones,myocardial infarction less than 
6 months, unstable angina, severe 
retinopathy, severe renal 
involvement or recurrent acute 
complications, HbA1c more than 8%
15 different homeopathic 
remedies
n=89 To eveluate the potential role of 
homeopathic medicines in 
themanagement of diabetic 
neuropathy
365  A statistically significant 
improvement in total diabetic 
distal symmetric polyneuropathy 
symptom scorewas found at 12 
months from baseline. Most 
objective measures did not show 
significant improvement
NR
Pomposelli R, 2009 Diabetic 
polyneuropathy
n=77 The groups were well 
balanced
Patient with diagnosis of 
polyneuropathy
Patients with other severe chronic 
diseases (detailed list in publication)
Individualized homeopathy and 
conventional treatment (n=45) 
vs conventional treatment 
(n=32)
n=13 vs n=3 Evaluate homeopathic therapy in 
diabetic neuropathy
365 Feasible and promising effects 
were observed for homeopathy in 
symptoms scores and QOL 
A grant from Belladonna 
Association (Milan, Italy)
Rabe A, 2004 Mild viral infections n=485 The groups were 
incompletely balanced for 
age, eye and ear infections 
Patients with mild or 
medium symptoms of acute 
respiratory  viral infections 




The hypothesis was that complex 
homeopaty could be as effective and 
safe as conventional therapies
28 Gripp-Heel had beneficial effects 
compared to conventional 
therapies in viral infections 
A grant from Biologische 
Heilmittel Heel GmbH, Baden-
Baden, Germany
Reily D, 2001 Upper and lower 
respiratory tract and 
ear complaints
n=456 patients; n= 30 
clinicians
The groups were well 
balanced apart from age
Older than one month, one 
main chief complaint (onset 
> 7 d before)
Patients with psychiatric disorders or 
severe chronic diseases (detailed list 
in publication)
Homeopathic remedies in D30 
(n=281) vs antibiotics, 
antiasthmatics and nasal 
preparations (n=175)
n=30 vs n=14 Compare the effectiveness of 
homeopathy with conventional 
medicine in real life settings
28 Homeopathy was as effective as 
conventional medical care
 HomInt, Karlsruhe, Germany
Rossi E, 2012 Homeopathic 
aggravations
n=1,110 A singel group which was 
descriptively reported in 
publication
Patients seeking 
homeopathic treatment at 
a homeopathic clinic
NR Collected data from all patients 
consecutively visiting the clinic 
(n=441)
n=669 Evaluate the typology, intensity and 
frequency of homeopathic 
aggravations
420 Homeopathic aggravations 
manifested themselves 1-2 days 
after administration of the remedy
NR
Sahid Ali M, 2009 Acute Diarrhoeal 
Disease
 n= 68 children A single group which was 
descriptively reported in 
publication
Children with acute 
diarrhoe (minimum 3 
unformed stools per day for 
at least 2 consecutive days)
Diarrhoe > 7 days, high-grade fever, 
severe dehydration, HIV, conditions 
requiring emergency procedures
Individualized classical 
homeopathy based on 11 out of 
14 trial medicines (n=68)
NR Evaluate the effects of homeopathic 
treatment for acute diarrhoeal 
disease
7 Diarrhoe index score improved 
significantly over time. 66 of 68 
children were cured.
NR
Schmieder V, 2006 Upper respiratory 
infections
n=397 A slightly higher number of 
women in the homeopathy 
group. They were also 
shorter than those in the 
control group
Symptoms of upper 
respiratory infections 
associated with common 
cold
Patients with bacterial infections, 
asthma, treated with antibiotics or 
similar therapies 
Complex homeopathy (n=175) 
vs conventional therapy (n=222)
NR Compare the effect of complex 
homeopathy with conventional over 
the counter therapy
14 Symptoms were reduced in both 
groups. No statistical differences 
between groups
Biologische Heilmittel Heel 
GmbH
Schneider C, 2005 Acute symtomatic 
tendinopathy
n=357 The groups were well 
balanced
>18 years old with acute or 
recurring tendinopathy of 
various aetiology
Patients receiving other NSAID 
therapies
Complex homeopathy (n=160) 
vs conventional therapy (n=197)
NR Assess the non-inferiority of complex 
homeopathy to conventional 
medicine
28 Symptoms were reduced in both 
groups. No statistical differences 
between groups
NR
Schneider C, 2008 Injuries n=133 The groups were well 
balanced
New or recurrent injuries 
and trauma diagnosed 
according to international 
classifications
Patients already undergoing 
treatment for injuries, without data 
for three months, using unknown 
medication 
Traumeel (mono or in 
combination with homeopathic 
theraphy)  (n=53) vs 
conventional medication and 
functional treatment (n=50)
n=16 vs n=14 Assess the daily use, effectiveness 
and safety of complex homeopathy 
compared with conventional 
medicine
90 Traumeel was as effective as 
conventional medicine
 Biologische Heilmittel Heel 
GmbH
Schröder D, 2003 Mild cardiac 
insufficiency (NYHA II)
n=212 The groups were well 
balanced, but there was a 
difference in sex distribution 
between groups
Patient diagnosed with mild 
cardiac insufficiency NYHA 
class II, necessitating 
therapy
Patients with unstable coronary heart 
disease, concomitant cardiac therapy
Cralonin drops (n=110) vs ACT 
inhibitor and/or diuretic 
therapy (n=102)
NR Assess the non-inferiority of complex 
homeopathy  to conventional 
medicine
60 Cralonin was non-inferior to usual 
ACE inhibitor/diuretic treatment
 Biologische Heilmittel Heel 
GmbH
Sevar R, 2005 Chronic illness n=455 A singel group which was 
descriptively reported in 
publication
Patients visiting a private 
homeopathic clinic
Not reported in publication Individualized homeopathy 
(n=436)
n=19 Outcome audit for patients with 
chronic illness
365 Chronically ill patients may benefit 
from homeopathic treatment 
when integrated in their 
management
NR
Teut M, 2010 Homeopathic 
treatment of elderly 
patients
 n=83 A singel group which was 
descriptively reported in 
publication
Patients > 70 years of age 
consulting a physician for 
the first time 
Not reported in publication Individualized homeopathy 
(n=83)
29 Determine the spectrum of 
diagnosis, treatment, course of 
illness in elderly who receive 
homeopathy
730 The study demonstrated 
substantial improvements 
following homeopathic treatment
Karl and Veronica Carstens 
Foundation, Essen, Germany
Study ID   Indication Intervention Dropout Objectives Duration of 
treatment 
Main results Funding
Sample size Baseline comparability Inclusion Exclusion Treatment vs Control (n) Treatment vs 
Control (n)  Days
               Participants                    Criteria
Thompson EA, 2003 Symptoms of 
oestrogen withdrawal 
in breast cancer 
patients
n=43 A singel group which was 
descriptively reported in 
publication
Patients referred to a 
homeopathic hospital with 
breast cancer and 
symptoms of oestrogen 
withdrawal 




Investigate the homeopathic 
approach, the impact on mood and 
QOL in these patients
Homeopathy appears to be 
clinically useful. Mood disturbance 
and QOL were improved
NR
Toelg M, 2009 Katarrhal or allergic 
conjunctivitis 
n=121 patients; n=28 
CAM-oriented 
physicians
A single group which was 
descriptively reported in 
publication
Children younger than 16 
years with clinically proven 
conjunctivitis
NR Treatment with Euphrasia D3 NR Evaluate efficacy and safety of 
Euphrasia D3 on children with 
katarrhal or allergic conjunctivitis 
10 Efficacy was rated as very good in 
93% of the patients, and safety 
was rated as very good in 99% of 
the patients and physicians 
NR
Waisse-Priven S, 2009 Dermatological 
complaints
n=51 A singel group which was 




visiting a public outpatient 
clinic 
Lack of compliance with prescription, 
follow-up and discontinuation of 
other therapeutic modalities
Individualized homeopathy and 
general medical advice (n=31)
n=20 Assess the effectiveness of 
homeopathy on dermatological 
complaints
90 Significant improvement was 
observed in 59% of the patients
The study had no sponsors
Walach H, 2001 Chronic headache n=18 Patients from a previous RCT 
agreed to be followed up for 
1 year
Headache diagnosed 
according to International 
Headache Society and 
standard criteria used in 
headache/migraine trials
NR Individualized homeopathy 
(n=13) vs placebo (n=5)
NR Assess the long-term effect of 
individualized homeopathy (followed 
by an RCT of chronic headache)
365 This study demonstrated effects of 




Waldschülz R, 2008 Insomnia n=409 The groups were well 
balanced
Mild to moderate sleep 
disturbance, diagnosed less 
than 4 weeks prior to the 
study
Concomitant diseases and 
intolerance to study medication
Neurexan (n=156) vs Valerian 
(n=164)
n=41 vs n=48 Assess the non-inferiority of complex 
homeopathy with a herbal product
28 Quality of sleep improved in both 
groups with no significant 
differences between groups
NR
Witt CM, 2008 Long lasting chronic 
disease
n=2722 A singel group male adults 
were underrepresented in 
this sample
Patients were included 
consecutively upon first 
consultation with a 
participating homeopathic 
physician
No restriction on diagnosis were 
made
Individualized homeopathy as a 
monotherapy or in combination 
with complementary or 
conventional therapies n= 
(2,722)
n=987 Evaluate health status changes under 
homeopathic treatment in routine 
care
2920 Substantial health improvement in 
patients under homeopathic 
treatment which lasted throughout 
the entire observation period
Karl and Veronica Carstens-
Foundation, Essen, Germany
Witt CM, 2009 Atopic eczema in 
children
n=135 patients (1-14 
years)
The groups were well 
balanced. Trend to longer 
symptoms duration in 
homeopathic group
Atopic eczema with at least 
6 months' disease duration 
and fulfill 3 of 4 of the 
Williams' criteria. Between 
2-7 at the three-Items 
severity score
Children with other dermal, medical 
and psychological diseases (detailed 
list in publication)
Individualized homeopathy 
(n=48) vs conventional 
medicine   (according to 
German guidelines) (n=87)
n=15 vs n=35 Examine the effectiveness, safety 
and costs of homeopathic vs 
conventional treatment in usual care
730 Both groups improved in 
symptoms. No statistical 
differences between groups
Karl and Veronica Carstens-
Foundation, Essen, Germany
Witt CM, 2009 Chronic low back pain n=129 patients; n=48  
homeopathic 
physicians
A singel group. 76 patients 
expected homeopathy to be 
helpful, 51 was uncertain 
and 1 was pessimistic
Patients with low back pain: 
lumbago, acute or chronic 
pain in lumbar or sacral 
regions
NR Individualized homeopathic 
treatment (129)
NR Evaluate homeopathy as a whole 
treatment system in usual care 
settings
365 Substantial improvements were 
found. Symptoms improved 
around half of the baseline and 
remained at this level
Karl and Veronica Carstens-
Foundation, Essen, Germany
Witt CM, 2009 Dysmenorrhea n=139 patients; n=57 
homeopathic 
physicians
A singel group which was 
descriptively reported in 
publication
Patients were included 
consecutively upon first 
consultation with a 
participating homeopathic 
physician
NR Individualized homeopathic 
treatment in addition to NSAID 
and contraceptive hormones 
(n=139)
NR  Presenting contemporary 
homeopathic health care and its 
outcome
730 Symptoms improved under 
homeopathic treatment. Use of 
conventional medication changed 
little
Karl and Veronica Carstens-
Foundation, Essen, Germany





A singel group which was 
descriptively reported in 
publication
Patients with headache 
defined according to: ICD-
9:784.0, ICD-10:R51 were 
included
NR Individualized homeopathy, 
when needed, conventional 
medicine was prescribed 
(n=304)
NR Evaluate homeopathy as a whole 
treatment system in headache in 
usual care settings
730 Substantial improvement was 
found assessed by health related 
QOL
Karl and Veronica Carstens-
Foundation, Essen, Germany
Witt CM, 2010 Migraine n=212, n=67 
homeopathic 
physicians
A singel group which was 
descriptively reported in 
publication
Patients with migraine 
diagnosed after (ICD-
9):346.9,ICD-10:G43.9




conventional medicine was 
prescribed (n=212)
NR Evaluate the use and effects of 
homeopathic treatment for migraine 
in usual care settings
730 Relevant improvement was found, 
persisting throughout the 
observational period
Karl and Veronica Carstens-
Foundation, Essen, Germany
Zanasi A, 2015 Upper respiratory 
tract infection (URTI)
n=85 children The groups were well 
balanced
Patient aged between 4 and 
15 years, cought induced by 
URTI lasting 5 days or less
Children with pre-existing respiratory 
problems, with antibiotic or other 
medical treatment that may effect 
the cough within 5 days
Homeopathic syrup [Stodal] 
(n=46) vs homeopathic syrup 
and antibiotics (n=39)
NR Evaluate if the addition of antibiotics 
to a symptomatic treatment 
(homeopathic syrup) improved 
cough resolution in pediatric patients 
with acute cough due to 
uncomplicated URTI. Verify the 
safety of the treatments
28 Cough was significantly reduced in 
both groups.No significant 
difference in cough severity and 
resolution were found between 
the groups. The antibiotic group 
presented more adverse effects 
than the homeopathy group
The study was sponsored by 
Boiron SA, Messimy, France, 
the holder of the marketing 
authorization of the study 
preparation.
Classical homeopathy: Prescribing a single remedy according to the simile law. Complex homeopathy: A combination of a number of homeopathic agents or remedies. Homeopathic immunetherapy: Homeopathic (ultramolecular) dosis of an allergen, Isopathy: A homeopathic subform, in which the preparations are made from the exact illness or 
its biproducts, QOL: Quality of life. AE: Adverse effects. HA: Homeopathic aggravations. NR: Not reported in publication.
